South African drug maker Adcock Ingram Holdings Ltd has exited its pharmaceutical operations in India by selling its drug marketing and sale business to India-focused private equity firm Samara Capital Partners Fund II Ltd for Rs.151 crore, the company said on Wednesday.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
